Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

Human medicines: European public assessment reports (EPARs)

Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.

Follow now 257 followers

Latest posts

Last updated about 16 hours ago

Human medicines European public assessment report (EPAR): Extavia, interferon beta-1b, Date of authorisation: 20/05/2008, Revision: 26, Status: Authorised

about 16 hours ago

Human medicines European public assessment report (EPAR): Extavia, interferon beta-1b, Date of...

Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation: 22/05/2014, Revision: 31, Status: Authorised

about 16 hours ago

Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation...

Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation: 27/05/2015, Revision: 29, Status: Authorised

about 16 hours ago

Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation...

Human medicines European public assessment report (EPAR): Pelmeg, pegfilgrastim, Date of authorisation: 20/11/2018, Revision: 10, Status: Authorised

about 17 hours ago

Human medicines European public assessment report (EPAR): Pelmeg, pegfilgrastim, Date of authorisation...

Human medicines European public assessment report (EPAR): BroPair Spiromax, salmeterol,fluticasone propionate, Date of authorisation: 26/03/2021, Revision: 2, Status: Authorised

about 20 hours ago

Human medicines European public assessment report (EPAR): BroPair Spiromax, salmeterol,fluticasone propionate, Date...

Human medicines European public assessment report (EPAR): Bortezomib Accord, bortezomib, Date of authorisation: 20/07/2015, Revision: 15, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Bortezomib Accord, bortezomib, Date of...

Human medicines European public assessment report (EPAR): Slenyto, melatonin, Date of authorisation: 20/09/2018, Revision: 13, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Slenyto, melatonin, Date of authorisation...

Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Date of authorisation: 11/11/2016, Revision: 20, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Date of authorisation...

Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine,naloxone, Date of authorisation: 10/11/2017, Revision: 13, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine,naloxone, Date of authorisation...

Human medicines European public assessment report (EPAR): Evista, raloxifene, Date of authorisation: 05/08/1998, Revision: 31, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Evista, raloxifene, Date of authorisation...

Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 32, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of...

Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 17, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of...